Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iradimed (IRMD) Free Cash Flow (2016 - 2025)

Historic Free Cash Flow for Iradimed (IRMD) over the last 13 years, with Q3 2025 value amounting to $5.8 million.

  • Iradimed's Free Cash Flow rose 1023.0% to $5.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.8 million, marking a year-over-year decrease of 1714.65%. This contributed to the annual value of $17.6 million for FY2024, which is 19246.28% up from last year.
  • According to the latest figures from Q3 2025, Iradimed's Free Cash Flow is $5.8 million, which was up 1023.0% from $5.1 million recorded in Q2 2025.
  • In the past 5 years, Iradimed's Free Cash Flow registered a high of $5.8 million during Q3 2025, and its lowest value of -$1.7 million during Q1 2023.
  • In the last 5 years, Iradimed's Free Cash Flow had a median value of $3.3 million in 2021 and averaged $2.9 million.
  • Per our database at Business Quant, Iradimed's Free Cash Flow soared by 42730.77% in 2021 and then plummeted by 24768.5% in 2023.
  • Iradimed's Free Cash Flow (Quarter) stood at $3.3 million in 2021, then dropped by 13.73% to $2.8 million in 2022, then grew by 19.65% to $3.4 million in 2023, then dropped by 5.43% to $3.2 million in 2024, then skyrocketed by 82.94% to $5.8 million in 2025.
  • Its Free Cash Flow stands at $5.8 million for Q3 2025, versus $5.1 million for Q2 2025 and $594624.0 for Q1 2025.